Market Research Future published a half-cooked research report on Global Molecular Diagnostics Market. Report include Molecular Diagnostics Market in-depth analysis, future predictions, Industry size, share, and growth rate. Global Molecular Diagnostics Market is expected to grow at a CAGR of 9.6% during forecasted period 2018-2023.
The reagents used in molecular diagnostics play important role in primary diagnosis and treatment of diseases at molecular level. The instruments like PCR and next generation sequencing has shown reliable test results and are rapid in nature which resulting increasing demand in central laboratories diagnostics institutes. Moreover, molecular testing tools are providing better alternatives in detecting in infectious viral, bacterial and other pathogens.
All these factors are responsible for growth of the market positively. Furthermore, increasing prevalence of infectious diseases like influenza and human papillomavirus and others also boost the growth of the market. On the other hand, higher price of molecular diagnostic kits may hinder the growth of the market.
Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1171 .
Key players for Global Molecular Diagnostics Market
Hoffmann-La Roche Ltd. (U.S.), QIAGEN N.V. (the Netherlands), Hologic, Inc. (U.S.), Grifols (Spain), Abbott (U.S.), Siemens Healthcare GmbH (Germany), Bio-Rad Laboratories, Inc. (US), BD (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid (U.S.).
Regional Analysis for Global Molecular Diagnostics Market
On regional basis, the Molecular Diagnostics Market is segmented into America, Europe, Asia Pacific and Middle East & Africa.
America dominates the Global market for molecular diagnostics due to increasing demand for the advanced techniques and molecular diagnostics and higher expenditure in life science domain are the major factors for the growth of American market.
Europe records the second largest market share followed by Asia Pacific. Increasing prevalence of lifestyle and chronic diseases, increasing number of private diagnostic centres are the major factors responsible for growth of the market.
According to American Cancer Society, Asia Pacific region, contributes 44% of all cancer cases (6.4 million out of 14.1 million) and 51% of all cancer deaths (4.3 million out of 8.2 million) globally, whereas China representing the majority of the cancer burden.
On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.
Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/1171 .
Segmentation for Global Molecular Diagnostics Market
The Global Molecular Diagnostics Market is segmented on the basis of techniques, applications and end users. Based on the techniques, it is segmented into PCR (Polymerase chain reaction) and real-time PCR, fluorescence in-situ hybridization, microarray, transcription-mediated amplification, and next-generation sequencing. Based on applications, it is segmented into infectious diseases, oncology, blood screening, genetic testing, pharmacogenomics, human leukocyte antigen typing, coagulation, others. And based on end users, it is segmented into hospitals, diagnostic laboratories, academics and research institutions.
Few Brief Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
Do you have Query? Inquire @ https://www.marketresearchfuture.com/enquiry/1171 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312